Wegovy (Semaglutide) Weight Loss Injection Pen

Wegovy™ may affect the way some medicines work and some medicines may affect

the way Wegovy™ works. Tell your healthcare provider if you are taking other

medicines to treat diabetes, including sulfonylureas or insulin. Wegovy™ slows

stomach emptying and can affect medicines that need to pass through the stomach

quickly.

Ozempic® (semaglutide) Injection 0.5 mg or 1mgOzempic® Demonstration Pen (0.25

mg, 0.5 mg)For demonstration and training only. Not for patients or injection

into humans. Does not contain medicine. Only to be used by a health care

professional. Needles are not included.

Ozempic® (semaglutide) injection is available in 3 multiuse pens for more A1C

control1The Ozempic® injection is supplied as a clear, colorless solution in a

prefilled, disposable, single-patient-use pen in the following packaging

configurations

Minimum Order: 5 packs

Advance Information*

Wegovy (Semaglutide) Weight Loss Injection Pen is an innovative prescription medication designed specifically for adults struggling with obesity or overweight issues. Formulated with Semaglutide, this injectable solution (2.4 mg/0.75 ml) provides a reliable and effective pathway toward significant weight loss when combined with a reduced-calorie meal plan and increased physical activity. This treatment is ideal for individuals with a BMI of 30 or greater, or a BMI of 27 with weight-related medical complications. Users will appreciate the unique mechanism of action that Wegovy provides, which includes slowing stomach emptying and managing insulin levels effectively. High-quality and clinically tested, Wegovy allows users to take control of their weight loss journey. It's paramount to consult your healthcare provider regarding any other medications you might be taking, especially those for diabetes, as they may affect how Wegovy works. Each pen is disposable and pre-filled for ease of use, making it a practical solution for managing your weight over time.

Key Features

• Active Ingredient: Semaglutide
• Dosage: 2.4 mg/0.75 ml
• Usage: For adults with obesity (BMI ≥30) or overweight (BMI ≥27) plus weight-related health issues
• Administration: Subcutaneous injection
• Combined Use: Best utilized with a reduced-calorie meal plan and increased physical activity
• Pen Type: Prefilled, disposable, single-patient-use
• Minimum Order: 5 packs
• Storage Instructions: Store in a refrigerator, do not freeze
• Side Effects: May cause slow stomach emptying and affect absorption of other medications

Specifications

• Product Type: Weight Loss Injection
• Administration Route: Subcutaneous
• Form: Injection Pen
• Price Range: 100.00 - 150.00 €
• Manufacturer: Novo Nordisk
• Shelf Life: Check package for expiration
• Regulatory Status: Prescription only